Company intelligence / Profile preview

ContraMed

Ownership: Private
Development stage: Other

Overview

ContraMed develops the VeraCept IUD, a novel copper intrauterine device designed with a nitinol flexible frame and lower copper load to improve comfort and reduce bleeding; Phase 2 studies in the US are complete with strong preliminary efficacy and fewer side effects versus prior copper IUDs, with Phase 3 planning underway.

Therapeutic areas: Women's Health
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on ContraMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ContraMed.

Explore the full profile